Question

Difficulty: MediumRheumatology and Immunology

Autoantibodies serve as crucial diagnostic markers in evaluating systemic autoimmune conditions. Match each specific clinical manifestation profile with the autoantibody most characteristically associated with the underlying disease.

  • Gradual onset of xerostomia, bilateral parotid swelling, and keratoconjunctivitis sicca in a middle-aged adult.Anti-Ro/SSA antibodies
  • Skin thickening confined to the fingers and face, accompanied by episodic digit vasospasm and esophageal dysmotility.Anti-centromere antibodies
  • Development of a malar rash, polyarthralgia, and pleuritis following prolonged therapy with procainamide.Anti-histone antibodies
  • Sequential development of Raynaud phenomenon, hand edema, and overlapping clinical features of myositis and systemic sclerosis.Anti-U1 ribonucleoprotein antibodies

Answer

The clinical profiles appropriately map to their highly specific serologic autoantibody markers based on presentation.
Each autoantibody has a distinct diagnostic sensitivity and specificity profile that aligns with specific clinical syndromes. Anti-Ro/SSA strongly correlates with Sjögren syndrome; anti-centromere indicates limited cutaneous systemic sclerosis; anti-histone is the hallmark of drug-induced lupus; and anti-U1 RNP is absolutely required for the diagnosis of mixed connective tissue disease.

Step-by-Step Solution

1
Analyze the first clinical profile describing xerostomia, parotid swelling, and keratoconjunctivitis sicca.
Identified as classic Sjögren syndrome.
This autoimmune exocrinopathy targets salivary and lacrimal glands, which strongly correlates with anti-Ro/SSA antibodies.
2
Evaluate the profile featuring distal skin thickening, vasospasm, and esophageal dysmotility.
Identified as limited cutaneous systemic sclerosis (CREST syndrome).
The symptoms represent Calcinosis, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia, linked to anti-centromere antibodies.
3
Assess the clinical profile involving rash, arthritis, and pleuritis after taking procainamide.
Identified as drug-induced lupus erythematosus.
Procainamide is a classic high-risk medication for this condition, characterized by positive anti-histone antibodies.
4
Analyze the final profile involving overlapping features of multiple connective tissue diseases.
Identified as mixed connective tissue disease (MCTD).
MCTD requires the presence of clinical overlap features combined with positive anti-U1 RNP antibodies for diagnosis.

Key Concept

Serologic Autoantibody Associations in Rheumatologic Diseases
Rate this question